Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zarxio
Zarxio
Amgen, Novartis Court Case May Ease US Launch of Biosimilars
Bidness, ETC
Thu, 06/23/16 - 09:56 am
Amgen
Novartis
biosimilars
Zarxio
Supreme Court
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Fierce Pharma
Thu, 03/31/16 - 09:39 pm
Supreme Court
Sandoz
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Amgen Asks the Supreme Court to Reject Challenge to Ruling that Notice of Commercial Marketing is Mandatory, But Asks for Review of Patent Dance Ruling Just in Case
FDA Law Blog
Tue, 03/29/16 - 11:12 am
Amgen
patents
FDA
Zarxio
Neupogen
Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches
Fierce Pharma
Sat, 02/20/16 - 09:22 am
Sandoz
generics
Supreme Court
exclusivity
biosimilars
Zarxio
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
FDA Law Blog
Wed, 02/17/16 - 11:33 am
Sandoz
FDA
BPCIA
Amgen
Zarxio
Neupogen
Can Pharma Learn to Stop Worrying and Love Biosimilars?
Forbes
Thu, 02/11/16 - 08:28 am
biosimilars
Novartis
Celltrion
Pfizer
Zarxio
CT-P13
An update on first-ever US biosim Zarxio 2 weeks after its debut
BioPharma Dive
Fri, 09/18/15 - 11:42 am
Novartis
Sandoz
Zarxio
bioimilars
Amgen
Neupogen
First 'biosimilar' drug launches in the US, years after other countries
Yahoo/AP
Thu, 09/10/15 - 06:04 pm
biosimilars
Sandoz
Zarxio
Neupogen
Amgen
Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Sandoz
Zarxio
biosimilars
Novartis
drug launches
Amgen
Neupogen
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount
Yahoo/Reuters
Thu, 09/3/15 - 08:45 am
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Sandoz
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Amgen: Waiting for Clarity on Generic Biotech
Barron's
Fri, 08/21/15 - 11:05 am
Amgen
generics
biosimilars
Novartis
Sandoz
Neupogen
Zarxio
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
This Key Amgen Drug Is Setting a Precedent
Investopedia
Tue, 06/9/15 - 09:55 am
Amgen
Neupogen
Zarxio
Novartis
biosimilars
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Novartis
Neupogen
biosimilars
Zarxio
Amgen
Sandoz
Amgen motion to delay Neupogen biosimilar denied
Medical Marketing and Media
Fri, 04/17/15 - 08:44 am
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
Amgen loses another round in its battle to fend off a biosimilar rival
Marketwatch
Mon, 03/30/15 - 09:23 pm
Amgen
biosimilars
Neupogen
Zarxio
Novartis
Denied Again! Another Obstacle to Biosimilar First Launch Falls with FDA Rejection of Amgen’s Certification Petition
FDA Law Blog
Fri, 03/27/15 - 08:39 am
Amgen
biosimilars
FDA
Sandoz
Neupogen
Zarxio
Amgen to appeal rejection of bid to block Novartis biosimilar drug
Yahoo/Reuters
Wed, 03/25/15 - 03:18 pm
Amgen
Novartis
Neupogen
biosimilars
Zarxio
Amgen: The biotech that's getting on the biosimilar R&D bandwagon
BioPharma Dive
Wed, 03/11/15 - 08:38 am
Amgen
biosimilars
Zarxio
Neupogen
Pages
1
2
next ›
last »